Control Bionics Statistics

Total Valuation

Control Bionics has a market cap or net worth of AUD 10.31 million. The enterprise value is 9.79 million.

Market Cap	10.31M
Enterprise Value	9.79M

Important Dates

The next estimated earnings date is Monday, May 26, 2025.

Earnings Date	May 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Control Bionics has 294.61 million shares outstanding. The number of shares has increased by 126.86% in one year.

Current Share Class	n/a
Shares Outstanding	294.61M
Shares Change (YoY)	+126.86%
Shares Change (QoQ)	+9.11%
Owned by Insiders (%)	19.65%
Owned by Institutions (%)	5.81%
Float	114.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.95
PB Ratio	1.60
P/TBV Ratio	4.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.41
EV / Sales	1.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.75

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.07.

Current Ratio	1.61
Quick Ratio	1.27
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	-68.83

Financial Efficiency

Return on equity (ROE) is -98.08% and return on invested capital (ROIC) is -58.85%.

Return on Equity (ROE)	-98.08%
Return on Assets (ROA)	-48.68%
Return on Invested Capital (ROIC)	-58.85%
Return on Capital Employed (ROCE)	-102.88%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.59
Inventory Turnover	3.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.50% in the last 52 weeks. The beta is 0.07, so Control Bionics's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	-12.50%
50-Day Moving Average	0.04
200-Day Moving Average	0.06
Relative Strength Index (RSI)	39.06
Average Volume (20 Days)	202,061

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Control Bionics had revenue of AUD 5.28 million and -6.95 million in losses. Loss per share was -0.03.

Revenue	5.28M
Gross Profit	3.56M
Operating Income	-6.92M
Pretax Income	-6.95M
Net Income	-6.95M
EBITDA	-6.00M
EBIT	-6.92M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 972,229 in cash and 453,475 in debt, giving a net cash position of 518,754 or 0.00 per share.

Cash & Cash Equivalents	972,229
Total Debt	453,475
Net Cash	518,754
Net Cash Per Share	0.00
Equity (Book Value)	6.46M
Book Value Per Share	0.03
Working Capital	1.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.58 million and capital expenditures -13,263, giving a free cash flow of -5.59 million.

Operating Cash Flow	-5.58M
Capital Expenditures	-13,263
Free Cash Flow	-5.59M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 67.39%, with operating and profit margins of -130.97% and -131.48%.

Gross Margin	67.39%
Operating Margin	-130.97%
Pretax Margin	-131.48%
Profit Margin	-131.48%
EBITDA Margin	-113.56%
EBIT Margin	-130.97%
FCF Margin	n/a

Dividends & Yields

Control Bionics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-126.86%
Shareholder Yield	-126.86%
Earnings Yield	-67.36%
FCF Yield	-54.20%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Control Bionics has an Altman Z-Score of -3.91. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.91
Piotroski F-Score	n/a